Clinical Trial Update: Denosumab and Osteoporotic Vertebral Compression Fracture [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating denosumab for osteoporotic vertebral compression fracture.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporotic Vertebral Compression Fracture

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Osteoporotic Vertebral Compression Fracture | Phase 2, Phase 3 | Status: COMPLETED